Questions arise over diabetes drug recall
March 10, 2021 | 14:30
Following serious warnings among health agencies about possible cancer risks caused by the use of diabetes drug metformin, domestic and international pharmaceutical firms are being questioned over their code of ethics and being urged to take action in order to protect people’s health.
Mobile Version